Stemtech CORP 10-K annual reports

Stemtech Corporation reports a significant decline in annual revenue and a widening net loss for fiscal year 2025 amid supply chain disruptions and liquidity constraints.

Stemtech Corporation's latest 10-K filing reveals a reduced net loss and improved operating cash flow for 2024, yet highlights significant financial challenges including a substantial accumulated deficit, working capital deficiency, and material weaknesses in internal controls, raising substantial doubt about its ability to continue as a going concern.

Stemtech Corporation's 2023 annual report reveals a slight increase in net sales, a reduction in operating expenses, and a significant decrease in net loss compared to the previous year, alongside strategic moves to expand its market presence.